Colrain Capital’s Merck MRK Stock Holding History

Colrain Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,716	Closed	-$710K	–	77
2017 Q1	$710K	Sell	11,716 -22,920	-66%	-$1.39M	0.21%	61
2016 Q4	$1.95M	Sell	34,636 -1,834	-5%	-$107K	0.41%	49
2016 Q3	$2.17M	Sell	36,470 -1,572	-4%	-$91.9K	0.49%	42
2016 Q2	$2.09M	Sell	38,042 -3,406	-8%	-$181K	0.42%	42
2016 Q1	$2.09M	Sell	41,448 -87,770	-68%	-$4.3M	0.36%	45
2015 Q4	$6.51M	Sell	129,218 -1,782	-1%	-$89.8K	0.66%	38
2015 Q3	$6.17M	Sell	131,000 -824	-0.6%	-$43.8K	0.64%	39
2015 Q2	$7.16M	Sell	131,824 -13,624	-9%	-$764K	0.63%	40
2015 Q1	$7.98M	Sell	145,448 -14,040	-9%	-$795K	0.67%	40
2014 Q4	$8.64M	Sell	159,488 -24,628	-13%	-$1.37M	0.67%	39
2014 Q3	$10.4M	Sell	184,116 -21,339	-10%	-$1.2M	0.78%	39
2014 Q2	$11.3M	Sell	205,455 -42,776	-17%	-$2.33M	0.82%	39
2014 Q1	$13.4M	Sell	248,231 -96,416	-28%	-$4.99M	1%	31
2013 Q4	$16.5M	Sell	344,647 -36,156	-9%	-$1.65M	1.14%	29
2013 Q3	$17.3M	Sell	380,803 -70,527	-16%	-$3.22M	1.29%	27
2013 Q2	$20M	Buy	+451,330	New	+$20.2M	1.46%	24

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Colrain Capital's MRK Position: Q2 2017 in Review

Colrain Capital sold out of Merck (MRK) in Q2 2017, closing a stake of 11,716 shares — an estimated $710K sold.

Colrain Capital first reported a position in MRK in Q2 2013 and held it in 16 quarters. The position peaked at $20M in Q2 2013. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

Colrain Capital reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
Colrain Capital sold 11,716 Merck shares in Q2 2017, an estimated $710K.
Colrain Capital first reported a position in Merck in Q2 2013 and held it in 16 quarters.
Colrain Capital's Merck position peaked at $20M in Q2 2013.
1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Colrain Capital's 13F filing for Q2 2017, filed 10 Aug 2017.